oxidopamine has been researched along with Lassitude in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Excerpt | Relevance | Reference |
---|---|---|
"Chronic fatigue is a complex and little understood symptom for which there is no safe and effective pharmacotherapy." | 5.33 | Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. ( Brown-Borg, HM; Dhanasekaran, M; Manyam, BV; Tharakan, B, 2006) |
"Chronic fatigue is a complex and little understood symptom for which there is no safe and effective pharmacotherapy." | 1.33 | Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity. ( Brown-Borg, HM; Dhanasekaran, M; Manyam, BV; Tharakan, B, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tharakan, B | 1 |
Dhanasekaran, M | 2 |
Brown-Borg, HM | 1 |
Manyam, BV | 1 |
Uthayathas, S | 1 |
Karuppagounder, SS | 1 |
Tamer, SI | 1 |
Parameshwaran, K | 1 |
Degim, T | 1 |
Suppiramaniam, V | 1 |
2 other studies available for oxidopamine and Lassitude
Article | Year |
---|---|
Trichopus zeylanicus combats fatigue without amphetamine-mimetic activity.
Topics: Amphetamine; Analysis of Variance; Animals; Behavior, Animal; Chronic Disease; Dioscoreaceae; Fatigu | 2006 |
Evaluation of neuroprotective and anti-fatigue effects of sildenafil.
Topics: Animals; Fatigue; Male; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neuroprotective Agents; Oxidopamin | 2007 |